1. Introduction
===============

Hospitals and clinics are major reservoirs for large numbers of pathogenic bacteria comprised of resident and community introduced strains \[[@B1-ijerph-12-04231]\]. High usage of antibiotics to treat infections in patients serves as a selective pressure for resistance development and there are concerns with transmission and their long term survival in the environment \[[@B2-ijerph-12-04231]\]. Dissemination of antibiotic resistant bacteria (ARB) from hospitals can occur via various routes such as hospital wastewater, discharged patients and health care workers \[[@B2-ijerph-12-04231],[@B3-ijerph-12-04231]\]. Antibiotics in wastewater can arise from excretion in urine and faces, direct disposal of expired drugs, and accidental spilling; these events could serve as additional selective pressure on bacteria while in wastewater. An elevated level of antibiotics and other pharmaceuticals in the environments are considered favorable for the selection of antibiotic resistance and most probably important hotspots for horizontal gene transfer (HGT) of resistance genes, and therefore conducive sites for resistance evolution \[[@B4-ijerph-12-04231],[@B5-ijerph-12-04231],[@B6-ijerph-12-04231]\]. The possible persistence and further dissemination of ARB in natural aquatic environments could ultimately lead to an increase in the pool of antimicrobial resistance determinants. The transfer of resistance into current and emerging pathogens are major concerns that are being entertained with regards to the continuous introduction of ARB and their resistance genes into the environment.

*Enterococcus* spp. are Gram-positive, non-spore-forming organisms that belong to a group of organisms known as lactic acid bacteria with some species producing a protein called bacteriocin. They are commensal members of the normal intestinal flora of humans and animals and female genitourinary tract without causing any infection; enterococciare commonly found in humans and animal faces, and faecalenterococci e.g., *E. faecalis*, *E. faecium*, *E. durans* and *E. hirae* are used as indicators of sewage contamination \[[@B7-ijerph-12-04231]\]. They also indicate possible presence of disease causing pathogens that inhabit the gastrointestinal tracts of human and animals \[[@B8-ijerph-12-04231]\]. As indicators of the hygienic quality of water, *Enterococcus* spp. are considered to be more specific than the faecalcoli forms as a whole \[[@B9-ijerph-12-04231]\].

Even though enterococci are non-pathogenic under normal circumstances, they can become opportunistic pathogens once the commensally relationship with the host is disrupted \[[@B10-ijerph-12-04231]\]. The genus *Enterococcus* has more than 40 species. The most abundant species in the human intestine and most commonly isolated from enterococcal infection include *E. faecalis* and *E. faecium.* Other species that have also been detected include; *E. avium, E. casseliflavus, Enterococcus durans, E. sgallinarum* and *E. raffinosu* \[[@B11-ijerph-12-04231]\].

Enterococci may have different genes that directly or indirectly contribute to virulence \[[@B12-ijerph-12-04231]\]. Genes encoding virulence factors in enterococci include *asa*1, *efa*A, *ace, esp, cyl*A, *gel*E and *hyl*A \[[@B13-ijerph-12-04231]\]. The *asa*1 gene, a plasmid gene, encodes for an aggregation substance (AS) which is a protein that mediates binding to the host epithelium and this protein also facilitates plasmid exchange by mediating bacterial aggregation during conjugation.

The *efa*A gene is associated with evasion of the immune response. The *esp* gene encodes for the enterococcus surface protein (ESP), which participates in biofilm formation and is associated with colonization and persistence in the urinary tract. The *ace* gene encodes for a protein "adhesion of collagen" which mediates the association of bacteria to matrix protein of the host cell. The *hyl*A gene encodes for hyaluronidase which plays a role in increasing bacterial invasion. The *cylA* gene encodes for cytolysis which has the ability to lyse a range of cells both prokaryotic and eukaryotic. The *gelE* gene encodes for Zn-metalloendopeptidase, which has the ability to hydrolyzegelatine, casein, and hemoglobin \[[@B14-ijerph-12-04231]\].

One major attribute of the genus *Enterococcus* is its propensity to acquire and disseminate antimicrobial resistance determinants. Enterococci have become resistant to a wide range of antibiotics and resistance to penicillin, cephalosporins, amino glycosides, and clindamycin are due to the various intrinsic traits they express \[[@B15-ijerph-12-04231]\] while resistance to chloramphenicol, erythromycin, tetracycline, fluoroquinolones and vancomycin are examples of acquired resistance \[[@B15-ijerph-12-04231]\]. Nearly 30 years after vancomycin was medically introduced, vancomycin-resistant enterococci were reported and the trend has increased since then \[[@B16-ijerph-12-04231],[@B17-ijerph-12-04231],[@B18-ijerph-12-04231],[@B19-ijerph-12-04231]\]. In the late 1980s, the first clinical isolates of vancomycin-resistant strains of pathogenic *E. faecalis and E. faecium* appeared. That vancomycin resistant bacteria have the ability to transfer the vancomycin resistance determinant to other bacteria poses threats to human health. There are many documented phenotypes of vancomycin resistance which includes *van*A, *van*B, *van*C, *van*D, and *vanE* \[[@B20-ijerph-12-04231]\].Resistance phenotypes *vanA* and *van*B were described mainly in *E. faecalis* and *E. faecium*. Resistance phenotype *van*C was described in *E. casseliflavus* and *E. Gallinarum* \[[@B19-ijerph-12-04231]\].

This study was aimed at determining the antimicrobial resistance patterns of *Enterococcus* spp. recovered from both hospital and municipal wastewaters in Alice, Eastern Cape Province, South Africa as a continuation of our larger study on the reservoirs of antibiotic resistance in the environment.

2. Materials and Methods
========================

2.1. Sample Collection
----------------------

The Victoria hospital and the Fort Hare wastewater treatment plant are both situated in Alice. Alice is a university and an administrative headquarters of Noncore local Municipality, in the Amatole District of the Eastern Cape in South Africa. The Fort Hare WWTP receives Victoria hospital wastewater, domestic sewages and runoff water within Alice town. The wastewater originating from the Victoria hospital does not have any form of pretreatment before being discharged into the main drain that eventually goes to the Fort Hare wastewater treatment plant Wastewater samples were collected from two sites in Alice (discharged wastewater from Victoria hospital and the final effluent of the receiving wastewater treatment plant simultaneously). Sampling was carried out at regular intervals between the months of June and August, 2014. Two hundred milliliters (200 mL) of hospital wastewater and final effluent were collected per site. The wastewater was collected at the discharge point into the main storm drain while the final effluent was taken as it was being released into the receiving water body. A total of 64 samples were collected altogether; 32 samples from each sampling site during the sampling period. Samples were collected in sterilized 350 mL bottles, kept in ice boxes and transported to the laboratory for microbiological analysis.

### 2.1.1. Isolation, Identification, DNA Extraction and Molecular Confirmation and Speciation of *Enterococcus* spp.

Bacteriological analyses were performed by inoculating tubes containing 9.5 ml Tryptic Soy Broth (TSB) with 0.5 mL of the samples and incubated for 18 h at 37 °C. Tubes showing bacterial growths from each site were streaked onto selective agar plates (Bile Aesculin Azide Agar).The plates were incubated at 37 °C for 24 h. An isolated colony per plate with appropriate colonial characteristics in the differential medium was selected as presumptively positive \[[@B21-ijerph-12-04231]\].The ability to hydrolyze esculin in the presence of bile is a characteristic of enterococci which results in the production of esculent in that reacts with ferric citrate to form a dark brown or black colony. These black colonies were regarded as presumptive isolates and one colony per plate was further inoculated into TSB, and incubated at 37 °C for 24 h from which glycerol stock was prepared for future use.

The boiling method was used for DNA extraction upon resuscitation from the glycerol stock using TSB after overnight incubation at 37 °C. The bacterial suspension was centrifuged at 10,000 rpm for 10 min and supernatant was discarded and pellet washed with 200 µL saline and further centrifuged at 10,000 rpm for 10 min as previously described by Bai \[[@B22-ijerph-12-04231]\]. The supernatant was discarded and 150 µL of lysis buffer was added and cells were lysed in a heating block at 100 °C for 10 min. Lysed cells were centrifuged at 10,000 rpm for 10 minutes and the supernatant was used as DNA template.

A procedure previously described by Ke \[[@B23-ijerph-12-04231]\] was used for identification of the *Enterococcus* spp. Identification of enterococci was based on the detection of the genus-specific *tuf*-gene (product size 112 bp). The positive control used was *E. feacalis* ATCC 19433. The reaction mixture (25 µL) contained: 5 µL of the DNA template, 12 µL of Master Mix, 1 µL of each primer- Ent1 and Ent2, and 5 µL of nuclease free water. Sequences of applied primers are: Ent1 5'-TACTGACAAACCATTCAT GAT G-3' and Ent2 5'-AACTTCGTCACCAACGCGAAC-3'. The PCR cycling conditions consisted of the initial denaturation 94 °C/3 min, amplification---30 cycles (94 °C/30 s, 53 °C/45 s, 72 °C/60 s), final extension 72 °C/7 min. Amplification was verified by gel electrophoresis in 2% agarose stained with ethidium bromide and visualized with UV transluminator (ALLIANCE 4.7, Cambridge, United Kingdom,) and photographed.

A polymerase chain reaction (PCR) was performed for *Enterococcus* species identification as previously described by Jackson \[[@B11-ijerph-12-04231]\] in a singleplex PCR with primer pairs shown in [Table 1](#ijerph-12-04231-t001){ref-type="table"}. Amplification of species-specific genes was performed for the identification of these following species: *E. faecalis, E. faecium, E. hirae, E. durans*, and *E. casseliflavus*. The Dream Taq PCR Master Mix (2×) consisting of 4 mM MgCl~2~, 0.4 m Mdeoxynucleoside triphosphate mix and Taq polymerase enzyme (Thermo Scientific, Pittsburgh, PA, USA) and 10 p Mol of each primer pair was added to the reaction mixture in a PCR tube. PCRs were performed in a final volume of 25 µL consisting of 20 µL of master mix and 5 µL of DNA template. Following an initial denaturation at 95 °C for 4 min, products were amplified in 30 cycles of denaturation at 95 °C for 30 s, annealing at 52°C (*E. faecalis, E. durans* and *E. casseliflavus*) or 48 °C (for *E. faecium and E. hirae*) for 1 min, and elongation at 72 °C for 1 min followed by a final extension at 72 °C for 7 min. Five microliters of product was electrophoresed on a 2% Tris-borate-EDTA agarose gel containing 2 µg of ethidium bromide/ml to verify amplification of the targeted genes at 110 V for 45 min. A DNA molecular weight marker of 100 bp was used as the standard and photographed under UV light transilluminator (ALLIANCE 4.7) Molecular Imager Gel Doc.

ijerph-12-04231-t001_Table 1

###### 

PCR primers, products, and reference strains.

  -----------------------------------------------------------------------------------------------------------------
  Strain                         Primer   Sequence (5'--3')         Product Size(bp)   Ref.
  ------------------------------ -------- ------------------------- ------------------ ----------------------------
  *E.faecalis* ATCC 19433        FL1\     ACTTATGTGACTAACTTAACC\    360                \[[@B11-ijerph-12-04231]\]
                                 FL2      TAATGGTGAATCTTGGTTTGG                        

  *E.durans* ATCC 19432          DU1\     CCTACTGATATTAAGACAGCG\    295                \[[@B11-ijerph-12-04231]\]
                                 DU2      TAATCCTAAGATAGGTGTTTG                        

  *E.casseliflavus* ATCC 25788   CA1\     TCCTGAATTAGGTGAAAAAAC\    288                \[[@B11-ijerph-12-04231]\]
                                 CA2      GCTAGTTTACCGTCTTTAACG                        

  *E.faecium* ATCC19434          FM1FM2   GAAAAAACAATAGAAGAATTAT\   215                \[[@B11-ijerph-12-04231]\]
                                          TGCTTTTTTGAATTCTTCTTTA                       

  *E.hirae* ATCC 8043            HI1\     CTTTCTGATATGGATGCTGTC\    187                \[[@B11-ijerph-12-04231]\]
                                 HI2      TAAATTCTTCCTTAAATGTTG                        
  -----------------------------------------------------------------------------------------------------------------

### 2.1.2. Detection of Virulence Genes

Two multiplex PCRs were used to screen for six virulence genes as previously described by \[[@B24-ijerph-12-04231],[@B25-ijerph-12-04231]\] with little modification making use of the primer pairs as shown in [Table 2](#ijerph-12-04231-t002){ref-type="table"}. The six virulence genes screened among all the confirmed *Enterococcus* isolates were *ace, efa*A, *gel*E, *esp, cyl and hyl.* Multiplex group 1 was *ace* and *gel*E and multiplex group 2 were *efa*A, *esp, cyl* and *hyl*.

PCR cycling conditions used for multiplex group 1 was as follow: initial denaturation at 94 °C for3 min; followed by 35 cycles of amplification (93 °C/1 min, 50 °C/1 min, 73 °C/1 min) and final extension at 72 °C/10. Similar conditions were used for multiplex group 2 except that the annealing temperature was 56.5 °C/1 min. The products were resolved in 2% gel electrophoresis stained with ethidium bromide and visualized with UV transluminator (ALLIANCE 4.7) and photographed.

ijerph-12-04231-t002_Table 2

###### 

Primers used to screen for virulence genes.

  Gene and Primers   Sequence                         Product Size (bp)   Ref.
  ------------------ -------------------------------- ------------------- ----------------------------
  *ace*                                               320                 \[[@B24-ijerph-12-04231]\]
  ACE1               5'-AAAGTAGAATTAGATCCACAC-3'                          
  aceACE1ACE2        5'-TCTATCACATTCGGTTGCG-3'                            
  *gelE*                                              402                 \[[@B24-ijerph-12-04231]\]
  gelE1              5'-AGTTCATGTCTATTTTCTTCAC-3'                         
  gelE2              5'-CTTCATTATTTACACGTTTG-3'                           
  *efaA*                                              499                 \[[@B24-ijerph-12-04231]\]
  efaA1              5'-CGTGAGAAAGAAATGGAGGA-3'                           
  efaA2              5'-CTACTAACACGTCACGAATG-3'                           
  *esp*                                               913                 \[[@B25-ijerph-12-04231]\]
  ESP46              5'-TTACCAAGATGGTTCTGTAGGCAC-3'                       
  ESP47              5'-CCAAGTATACTTAGCATCTTTTGG-3'                       
  *hyl*                                               276                 \[[@B25-ijerph-12-04231]\]
  HYL n1             5'-ACAGAAGAGCTGCAGGAAATG-3'                          
  HYL n2             5'-GACTGACGTCCAAGTTTCCAA-3'                          
  *cylA*                                              688                 \[[@B25-ijerph-12-04231]\]
  CYT I              5'-ACTCGGGGATTGATAGGC-3'                             
  CYT II             5'-GCTGCTAAAGCTGCGCTT-3'                             

2.2. Antimicrobial Susceptibility Testing
-----------------------------------------

The Kirby-Bauer disk diffusion method was used as described by \[[@B26-ijerph-12-04231],[@B27-ijerph-12-04231]\] to evaluate the antimicrobial susceptibility profiles of the isolates using standardized single disk on Muller-Hinton agar (MHA). Antibiotics that are more frequently used and prescribed in Victoria hospital were selected for testing which are erythromycin (15 µg), imipenem (10 µg), tetracycline (30 µg), cefotaxine (30 µg), gentamicin (10 µg), clindamycin (2 µg), kanamycin (30 µg), vancomycin (30 µg), ciprofloxacin (5 µg) and penicillin 10 units.

### PCR Detection of *van*A, *van*B, *van*C1, *van*C2*/3* and *erm*(B) Genes

The genes encoding vancomycin resistance were investigated among the isolates using the previously extracted genomic DNA and PCRs were performed in a BioRad Thermal Cycler (Foster, CA, USA). The oligonucleotide primers for PCR amplifications were synthesised by Inqaba Biotech (Pretoria, South Africa). Primer sequences for *van*A, *van*B, *van*C1, *van*C2/3 genes were those previously described by Nam \[[@B28-ijerph-12-04231]\]. The list of the specific primers used in the study and their amplification products are shown in [Table 3](#ijerph-12-04231-t003){ref-type="table"}. The reactions were performed as singleplex in a total volume of 25 µL, using 5 µL of cell lysate as DNA template, 10 pmol of each of the forward and reverse primers, 12 µL of Dream Taq master PCR mix (Thermo Scientific, Pittsburgh, PA, USA) and 6µL of PCR water grade. Cycling conditions were as follows: a first denaturation step of 94 °C for 3 min, 35 cycles of denaturation at 94 °C for 1 min, annealing at 56.5 °C (*van*B, C1, and C2/3) and 55 °C for *erm* (B) for 1 min, extension at 72 °C for 1 min, followed by an elongation step at 72 °C for 10 min. The PCR products were analyzed in 2% agarosegel stained with ethidium bromide, electrophoresed at 110 V for 45 min, visualized under UV transilluminator (ALLIANCE 4.7) and photographed.
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###### 

Oligonucleotide primers used to identify resistance genes.

  Gene(s)                      Product Size (bp)   Primer Name Oligonucleotide Sequences (5' to 3')   Ref.
  ---------------------------- ------------------- -------------------------------------------------- ----------------------------
  *van*A                       314                 AF-GCGCGGTCCACTTGTAGATA                            \[[@B29-ijerph-12-04231]\]
  AR-TGAGCAACCCCCAAACAGTA                                                                             
  *van*B                       220                 BF-AGACATTCCGGTCGAGGAAC                            \[[@B29-ijerph-12-04231]\]
  BR-GCTGTCAATTAGTGCGGGAA                                                                             
  *van*C-1                     402                 C1F-ATCCAAGCTATTGACCCGCT                           \[[@B29-ijerph-12-04231]\]
  C1R-TGTGGCAGGATCGTTTTCAT                                                                            
  *van*C-2/3                   582                 C2F-CTAGCGCAATCGAAGCACTC                           \[[@B29-ijerph-12-04231]\]
  *erm*(B)                     320                 C2R-GTAGGAGCACTGCGGAACAA                           \[[@B30-ijerph-12-04231]\]
  BN1-CGAGTGAAAAAGTACTCAACCA                                                                          
  BN2-CGGTGAATATCCAAGGTACG                                                                            

3. Results
==========

3.1. Identification of Enterococcus to Species Level
----------------------------------------------------

Out of 66 presumptive samples, 62 (93.93%) were confirmed to belong to the *Enterococcus* genus and made up of 33 from hospital wastewater and 29 from final effluents of the municipal WWTP. Some of the results for the presumptive identification and molecular confirmation of *Enterococcus* isolates are shown in the gel electrophoresis image in [Figure 1](#ijerph-12-04231-f001){ref-type="fig"}. The 62 confirmed enterococci were further analyzed for species identification. The following species were targeted; *E. faecalis, E. durans, E. casseliflavus, E. faecium,* and *E. hirae* because of their frequent occurrence in human infections as reported in literatures. A total of 30 isolates (19 from hospital wastewater and 11 from the final effluent of the WWTP) were identified to be *E. faecalis* and 15 isolates (five from hospital wastewater and 10 from final effluent of WWTP) were identified to be *E. durans*. The remaining 17 isolates could not be delineated by the primes used in species identification because they were outside the species that were screened for. Some of the results for *Enterococcus* speciation are shown in the gel electrophoresis image in [Figure 2](#ijerph-12-04231-f002){ref-type="fig"}.

3.2. Identification of Virulent Genes
-------------------------------------

The DNA extract from the 62 confirmed enterococci isolates were further analyzed for virulence gene identification. Virulence genes that were targeted include *ace, efa*A, *gel*E, *esp, cyl* and *hyl*A. A total of 19 isolates that were positive for the *efa*A gene (15 from hospital wastewater and four from final effluent of WWTP); 15 isolates were positive for the *ace* gene (two from hospital wastewater and 13 from final effluent of WWTP), and three isolates were positive for the *gel*E gene (from final effluent). The rest of the isolates did not harbor any virulence genes. Some of the results for the enterococcus virulent genes obtained from this study are shown in the gel electrophoresis image in [Figure 3](#ijerph-12-04231-f003){ref-type="fig"}.

![Gel imagerepresenting molecular confirmation of *tuf*-gene (112bp) of *Enterococcus* from hospital wastewater and final effluent of WWT P.L: ladder, PC: positive control *E. faecalis* ATCC 19433; NC: negative controlwas PCR mix without DNA; lanes 1--11 are confirmed enterococci isolates.](ijerph-12-04231-g001){#ijerph-12-04231-f001}

![Gel imagerepresenting molecular confirmation of *Enterococcus* species *E. faecalis* (360bp), *E. durans* (295bp) from hospital wastewater and final effluent of WWTP. L: 100bp ladder (Gene Ruler); NC: negative control was PCR mix without DNA; lane 1 *E. feacalis* ATCC 19433; and lanes 2--12 are delineated isolates.](ijerph-12-04231-g002){#ijerph-12-04231-f002}

![Gel image representing molecular identification of virulent genes *ace* (320bp) and *gel*E (402) from hospital wastewater and final effluent of WWTP. Lane 1 is 100bp ladder (Gene Ruler), lane 2 is negative control, lane 3--12: samples/isolates.](ijerph-12-04231-g003){#ijerph-12-04231-f003}

3.3. Antimicrobial Susceptibility Profile of Confirmed Enterococcus Isolates from Hospital Wastewater
-----------------------------------------------------------------------------------------------------

Susceptibilities of the isolates from hospital wastewater were tested against ten different antibiotics and the results indicate high antibiotic resistance among the isolates. Approximately 67% to 100% of the isolates were resistant to penicillin, erythromycin, cefotaxime, gentamicin, imipenem, tetracycline, kanamycin, ciprofloxacin, vancomycin, and clindamycin ([Figure 4](#ijerph-12-04231-f004){ref-type="fig"}). The observed phenotypic resistance patterns among the hospital wastewater isolates are shown in [Table 4](#ijerph-12-04231-t004){ref-type="table"}.

![The percentage of Antimicrobial resistance profiles of isolates from hospital wastewater. PG 10= Penicillin10 µg; E15 = Erythromycin 15 µg; CTX30 = Cefotaxime 30 µg; GM10 = Gentamicin 10 µg; IMI10 = Imipenem 10 µg; T30 = tetracycline 30 µg; K30 = kanamycin 30 µg; CIP5 = ciprofloxacin 5 µg; VA30= vancomycin 30 µg; CD2 = clindamycin 2 µg.](ijerph-12-04231-g004){#ijerph-12-04231-f004}
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###### 

Prevalence of phenotypic resistance patterns of isolates from hospital wastewater.

  No. of Isolates   Phenotypic Multiple Resistance Patterns
  ----------------- -----------------------------------------
  16                PG/E/CTX/GM/IMI/T/K/CIP/VA/CD
  6                 PG/E/CTX /IMI/T/K/CIP/VA/CD
  7                 E/CTX /IMI/T/K/CIP/VA/CD
  4                 E/CTX/GM/IMI/T/K/CIP/CD

PG = Penicillin; E= Erythromycin; CTX = Cefotaxime; GM = Gentamicin; IMI = Imipenem; T= tetracycline; K = kanamycin; CIP = ciprofloxacin; VA = vancomycin; CD = clindamycin.

3.4. Antimicrobial Susceptibility Profile of Confirmed Enterococcus Isolates from the Final Effluent of Wastewater Treatment Plant.
-----------------------------------------------------------------------------------------------------------------------------------

Results of antimicrobial resistance/susceptibility profiles of isolates from final effluent of WWTP showed that all the isolates were resistant against the entire antibiotic tested against them with the exception of gentamycin where 76% of the isolates were resistant ([Figure 5](#ijerph-12-04231-f005){ref-type="fig"}) while the phenotypic resistance patterns are shown in [Table 5](#ijerph-12-04231-t005){ref-type="table"}.

![Antimicrobial resistance profiles of isolates from final effluent of WWTP. As seen in the graph, all the isolates were resistant to all the antibiotics with the exception of GM where resistance was 76%.](ijerph-12-04231-g005){#ijerph-12-04231-f005}
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###### 

Phenotypic resistance patterns of the isolates from hospital wastewater.

  Total No. of Isolates   Resistance Pattern of The Isolates
  ----------------------- ------------------------------------
  23                      PG/E/CTX/GM/IMI/T/K/CIP/VA/CD
  6                       E/CTX /IMI/T/K/CIP/VA/CD

PG = Penicillin, E = Erythromycin, CTX = Cefotaxime, GM = Gentamicin, IMI = Imipenem, T = tetracycline, K = kanamycin, CIP = ciprofloxacin, VA = vancomycin, CD = clindamycin.

3.5. Detection of Antimicrobials Resistance Genes *from Confirmed* Enterococcus *Isolates*
------------------------------------------------------------------------------------------

Among the genes investigated for vancomycin resistance, *van*A was not detected while there was preponderance of *van*B, *van*C1 and *van*C2/3 genes. All the isolates that were phenotypically resistant to vancomycin were positive for *van*B, *van*C1 *van*C2/3 and 40 for *erm*(B) genes as shown in [Table 6](#ijerph-12-04231-t006){ref-type="table"}.

ijerph-12-04231-t006_Table 6

###### 

Frequency of resistance genes to macrolideand glycopeptide detected among the isolates.

  Antibiotic     Class          Resistance Gene               No. of Strain
  -------------- -------------- ----------------------------- ---------------
  Erythromycin   Macrolide      *erm*(B)                      40 (88.8%)
  Vancomycin     Glycopeptide   *van*B, *van*C1, *van* C2/3   42 (93.3%)

4. Discussion
=============

Water pollution is one of the key environmental problems facing South Africa. This pollution arises from many sources which include municipal effluents. Surveys and technical papers have reported that since 2004, 70% of municipality waste treatment facilities in South Africa face collapse due to lack of proper maintenance and expansion \[[@B30-ijerph-12-04231]\]. The failures of wastewater treatment plants to efficiently remove contaminants result in the production of poor quality effluents that are capable of causing the degradation of the receiving water bodies, such as lakes, rivers, streams and dams.

In this study, *Enterococcus* spp. were isolated and identified in both the hospital wastewater and final effluent of the wastewater treatment plant. Presence of *Enterococcus* spp. in the final effluent shows that the Fort Hare wastewater treatment plant may not be quite efficient with regards to removing bacteria in the final effluent that is discharged to receiving water bodies. Since enterococci are also used as indicators of sewage contamination, its presence in the Fort Hare WWTP final effluent indicated possible presence of pathogens like bacteria, viruses, protozoans and helminthes \[[@B8-ijerph-12-04231]\]. This study shows the inefficiency of the chlorination process in killing microorganisms in the final effluent discharged into the environment. The discharged final effluents could have harmful effects on the receiving water body \[[@B30-ijerph-12-04231]\].

The confirmed enterococci from both hospital wastewater and final effluent of WWTP were further analyzed for species identification and 48.39% were *E. faecalis* (30% from hospital wastewater and 18% from final effluent) and 24% were identified as *E. durans* (8% from hospital wastewater and 16% from final effluent), while the rest were unidentified. *E. faecalis* has become an agent that is commonly associated with nosocomial infections, urinary tract infections, endocarditis, bacteremia, neonatal infections, central nervous system (CNS) infections, and abdominal and pelvic infections \[[@B31-ijerph-12-04231]\]. *E. durans* has been isolated from patients with enterococcal infection \[[@B32-ijerph-12-04231]\].Bacterial species in general and *E. faecalis* specifically, can activate several survival strategies including starvation and the viable but non culturable (VBNC) state \[[@B33-ijerph-12-04231],[@B34-ijerph-12-04231]\] thus conserving their viability. Since enterococcal species may activate two different survival strategies, namely starvation and the VBNC state, depending on the specific environmental condition \[[@B35-ijerph-12-04231]\], this finding indicates that the final effluent discharged from the Fort Hare WWTP harboring *Enterococci* species is capable of causing infections in humans and animals that may come in contact with the discharged effluent.

Even though *Enterococcus* spp. are commensal in the guts of animals including humans, they are known to have virulence properties which could enable them to establish infections in certain categories of people whose immune systems have been compromised such as in elderly persons, children, pregnant women and long-term hospitalized patients. A high prevalence of genotypic virulence markers (*gel*E, *ace* and *efa*A) was detected in the isolated species, thus corroborating results of previous reports \[[@B24-ijerph-12-04231],[@B36-ijerph-12-04231],[@B37-ijerph-12-04231]\]. On the other hand, the following genes: -*hyl*A, *cyl*A and *esp* were absent in all species analyzed. The presence of *efa*A gene as previously reported by Abriouel \[[@B38-ijerph-12-04231]\], suggests that this gene is important for persistence of enterococci in environments other than human tissues. Virulence factors like collagen-binding protein (*ace*), enterococcal surface proteins (*esp*), and *E. faecalis* endocarditic antigen (*efa*A) plays a significant role in enterococcal adhesion to collagen and the extracellular matrix \[[@B39-ijerph-12-04231]\]. *E. faecalis* endocarditic antigen (*efa*A) was first identified from the antiserum of a patient with *E. faecalis* endocarditic \[[@B40-ijerph-12-04231]\]. The amino acid sequence of the associated protein *efa*A revealed 55%--60% homology to a group of streptococci proteins known as adhesions \[[@B40-ijerph-12-04231]\], hence it could be vital for attachment to surfaces and therefore aids in the organism's persistence in the environment.

To determine antibiotic sensitivity of the isolates, we tested the isolates against a panel of antimicrobial agents most of which were drugs commonly prescribed at the hospital that generated the wastewater under investigation. The results are alarming as almost all the isolates were resistant to glycopeptides (vancomycin) and macrolide (erythromycin). For hospital wastewater, 91% were resistant to vancomycin and isolates from the final effluent were 100% resistant. Several studies have documented a high incidence of antibiotic resistance in such wastewaters all over the world \[[@B4-ijerph-12-04231],[@B41-ijerph-12-04231],[@B42-ijerph-12-04231]\].

Out of several different genes mediating vancomycin resistance, *van*A, *van*B, *van*C1, and *van*C2/3 resistance genes were targeted for identification as these gene clusters can be acquired and often are transferable \[[@B20-ijerph-12-04231]\]. Genetic profiling of the resistance genes was successful for *erm*B, *van*B, *van*C1 and *van*C2/3 genes. Genetic determinants for vancomycin resistance were homogeneously detected in most of the isolates the source notwithstanding. Similarly, *erm*B was also present in more than 80% of the isolates that were phenotypically resistant to erythromycin and this is in agreement with previous reports on erythromycin resistance in *Enterococci* recovered from wastewaters \[[@B2-ijerph-12-04231],[@B43-ijerph-12-04231],[@B44-ijerph-12-04231],[@B45-ijerph-12-04231],[@B46-ijerph-12-04231]\]. These results showed that the WWTP could act as a reservoir of antibiotic resistant bacteria as well as resistant determinants. The results of this study arein agreement with a similar study that has reported high rates of antibiotic resistant bacteria in the wastewater environment \[[@B47-ijerph-12-04231]\]. Also, wastewater treatment plants have been documented as reservoirs of antibiotic resistant bacteria \[[@B48-ijerph-12-04231]\].

This study also observed that isotales from the hospital wastewater had a similar resistance pattern as those of the final effluent of the receiving WWTP as shown in [Figure 4](#ijerph-12-04231-f004){ref-type="fig"} and [Figure 5](#ijerph-12-04231-f005){ref-type="fig"} and [Table 4](#ijerph-12-04231-t004){ref-type="table"} and [Table 5](#ijerph-12-04231-t005){ref-type="table"} respectively. A high degree of similarity between the resistance patterns of the isolates recovered from hospital wastewater and final effluent of WWTP suggest that hospital wastewater could have contributed immensly to the resistances observed among the isolates from the final effluent. Hospitals are known to not only discharge pathogenic bacteria, most of which could be carrying resistance determinants into its wastewater, but also traces of antibiotics in urine, feces, as well as spilled and expired drugs that are improperly discarded into wash basins, are all channelled to the WWTP. Not all antibiotics in wastewater treatment plant undergo biodegradation. Many studies have shown low concentrations of antibiotics in treated water, which indicate a partial removal in waste water treatment plants \[[@B49-ijerph-12-04231],[@B50-ijerph-12-04231],[@B51-ijerph-12-04231],[@B52-ijerph-12-04231]\]. Several studies have pointed out that WWTPs can provide favorable environmental conditions needed for antibiotic resistance genes transfer \[[@B2-ijerph-12-04231],[@B53-ijerph-12-04231],[@B54-ijerph-12-04231]\]. The possibility for potential spread of specific genes encoding antibiotic resistance in wastewater treatment plants by horizontal gene transfer has also been reported \[[@B55-ijerph-12-04231],[@B56-ijerph-12-04231]\].

The presence of resistant enterococci in the hospital wastewater that is discharged to the Fort Hare WWTP and the observation of similaries in resistant patterns between hospital wastewater and final effluent of receiving WWTP suggest that the Victoria hospital wastewater could be a huge source of antibiotic resistant bacteria in the receiving WWTP. A similar study done by Lupo \[[@B57-ijerph-12-04231]\] about the relationship between antibiotic-resistance, bacterial community present in hospital wastewater, and wastewater treatment plant also identified hospital wastewater as a source of antibiotic resistance bacteria to the wastewater treatment plant. The limitations of this study are the sample size and low number of isolates analyzed. For a better picture to support these findings, a larger sample size and higher number of isolates needs to be analyzed. Further studies are therefore needed to validate these findings.

5. Conclusions
==============

The results of the study revealed the challenges inthe chlorination process; hence, the final effluent discharged to the environment still contained multi-resistant enterococci. It also suggests that the hospital wastewater may contribute to the resistance enterococci in the final effluent of the WWTP as the resistance patterns of the isolates were very similar thus indicating that the former could most likely be a reservoir of antibiotic resistant bacteria. The findings call for interventions by relevant authorities as it has great public health implications for the health of humans and animals that are exposed to the receiving water body.
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